mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.08 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0041 |
0.9 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |